Avion Wealth lifted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 497.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 460 shares of the company’s stock after acquiring an additional 383 shares during the period. Avion Wealth’s holdings in GE HealthCare Technologies were worth $35,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently made changes to their positions in GEHC. D1 Capital Partners L.P. bought a new stake in GE HealthCare Technologies in the 3rd quarter valued at about $268,159,000. Van ECK Associates Corp bought a new stake in GE HealthCare Technologies in the 3rd quarter valued at about $208,513,000. State Street Corp boosted its stake in GE HealthCare Technologies by 7.8% during the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company’s stock valued at $1,747,101,000 after purchasing an additional 1,347,114 shares during the last quarter. Massachusetts Financial Services Co. MA acquired a new position in GE HealthCare Technologies during the 3rd quarter valued at about $93,713,000. Finally, Jennison Associates LLC boosted its stake in GE HealthCare Technologies by 124.5% during the 4th quarter. Jennison Associates LLC now owns 1,709,635 shares of the company’s stock valued at $133,659,000 after purchasing an additional 948,017 shares during the last quarter. 82.06% of the stock is owned by institutional investors.
GE HealthCare Technologies Trading Down 0.5 %
Shares of GEHC stock opened at $87.03 on Wednesday. The company’s fifty day simple moving average is $83.52 and its two-hundred day simple moving average is $85.38. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.55. The stock has a market capitalization of $39.76 billion, a price-to-earnings ratio of 23.91, a PEG ratio of 2.93 and a beta of 1.15.
GE HealthCare Technologies Increases Dividend
Analyst Upgrades and Downgrades
A number of research firms have issued reports on GEHC. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company boosted their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. One research analyst has rated the stock with a sell rating, four have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $96.00.
View Our Latest Research Report on GE HealthCare Technologies
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Further Reading
- Five stocks we like better than GE HealthCare Technologies
- The Role Economic Reports Play in a Successful Investment Strategy
- GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends
- What is the Hang Seng index?
- The Fast and the Casual: Is Taco Bell Catching Up to Chipotle?
- Best Aerospace Stocks Investing
- Broadcom Stock: Why the Upside Is Too Good to Ignore
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.